 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Illumina Growing Clinical and Dx Business with Submission of MiSeqDx, Two CF Assays to FDA
January 09, 2013
Illumina Growing Clinical and Dx Business with Submission of MiSeqDx, Two CF Assays to FDA
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News - Illumina Acquires Moleculo, Pre-announces Q4 Revenue Growth of 8 Percent
January 8, 2013 / GenomeWeb Daily News - Illumina Plans to Submit MiSeqDx Assays for Cystic Fibrosis to FDA this Year
November 1, 2012 / Clinical Sequencing News - Illumina's Low-Cost MiSeq Promises to Speed up Next-Gen Sequencing
January 18, 2011 / In Sequence - NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News